Cutler Group’s Tectonic Therapeutic TECX Stock Holding History

Cutler Group’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8	Closed	-$1K	–	5626
2020 Q3	$1K	Sell	8 -9	-53%	-$1.81K	﹤0.01%	4499
2020 Q2	$3K	Buy	+17	New	+$3.5K	﹤0.01%	3682

Other funds holding TECX

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Cutler Group's TECX Position: Q4 2020 in Review

Cutler Group sold out of Tectonic Therapeutic (TECX) in Q4 2020, closing a stake of 8 shares — an estimated $1K sold.

Cutler Group first reported a position in TECX in Q2 2020 and held it in 2 quarters. The position peaked at $3K in Q2 2020. 105 funds tracked by Wall St. Rank hold TECX as of Q4 2020.

Cutler Group reported no remaining Tectonic Therapeutic position as of Q4 2020 after selling out during the quarter.
Cutler Group sold 8 Tectonic Therapeutic shares in Q4 2020, an estimated $1K.
Cutler Group first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 2 quarters.
Cutler Group's Tectonic Therapeutic position peaked at $3K in Q2 2020.
105 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.